Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101891571A details a Pd-catalyzed carbonylation route for unsaturated ketones. Offers high purity intermediates and streamlined supply chain solutions.
Patent CN102875455A reveals a scalable Hofmann degradation route for 3,6-dichloro-2-aminopyridine, eliminating cryogenic lithiation and reducing manufacturing costs significantly.
Novel patent CN103965089B offers improved stereoselective synthesis for Ezetimibe. Enhances optical purity and yield suitable for commercial scale-up and supply chain reliability.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN115010193A reveals a silver-free route for tetraammine platinum salts. Achieve >99% purity and reduced costs for industrial catalyst manufacturing.
Patent CN103467228A details a mild Pd-catalyzed allyl-aryl coupling for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and robust supply chain reliability.
Patent CN101781256B details a high-yield CDI-mediated amidation route for benzimidazole derivatives, offering cost reduction in API manufacturing and improved supply chain reliability.
Patent CN121039107A discloses a high-yield synthesis route for THR beta agonist intermediates. This method avoids SFC resolution, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN110330400A reveals Rh-catalyzed hydrogenation for high-purity intermediates. Offers cost reduction and supply reliability for pharma manufacturing partners seeking scalable solutions.
Patent CN115043787B reveals metal-free photocatalytic route. Offers significant cost reduction and supply chain reliability for high-purity oxazole intermediate manufacturing globally.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN113201516B reveals a solvent-free enzymatic route for L-menthol with >95% ee. Discover cost-effective manufacturing solutions for high-purity terpene alcohols.
Patent CN102219665B details a green Cu-SBA-15 catalyzed oxidation for Vitamin E precursors, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN111269228A reveals a green photocatalytic route for fluorescent indolizine derivatives, offering cost-effective manufacturing for pharma intermediates.
Patent CN106754775B details ScCR1 mutants for Atorvastatin intermediate. Offers high stability and activity for cost-effective manufacturing.
Novel regioselective sulfonylation process for DPP-IV inhibitor intermediates. Enhances purity and reduces purification steps for reliable pharmaceutical supply chains.
Patent CN104099305A reveals stable CgKR1 mutants for Clopidogrel intermediates. Enhances purity and supply chain reliability for global pharmaceutical manufacturing.
Advanced preparation method for Vonoprazan intermediates via Cobalt catalysis. Offers high yield, cost reduction, and reliable supply chain for pharmaceutical manufacturing.
Patent CN111056994B reveals a cost-effective vismodegib synthesis route using Michael addition, offering high purity and scalable manufacturing for global supply chains.
Novel 2-step synthesis of Imrecoxib avoids toxic chromium reagents, offering a cost-effective and scalable solution for pharmaceutical intermediates manufacturing.